CSPC PHARMA (01093): The trustee purchased a total of 5.8 million shares under the stock incentive plan.
China Resources Pharmaceutical Group (01093) announced that on June 22, 2026, the trustee purchased a total of 5.8 million shares of the company in the market according to the terms and conditions of the 2026 stock incentive plan, and held the shares in trust for the benefit of the selected participants.
CSPC PHARMA (01093) announced that on June 22, 2026, the trustee purchased a total of 5.8 million shares of the company in the market according to the terms and conditions of the 2026 Share Incentive Plan, and held these shares in trust for the benefit of selected participants.
Related Articles

Robotic Intelligent Technology (300757.SZ): Issuance of H shares has obtained approval from the China Securities Regulatory Commission.

JXR(01951) suggests launching an asset-backed securities program on the Shanghai Stock Exchange.

STREAM IDEAS (08401): Huang Zilu appointed as executive director.
Robotic Intelligent Technology (300757.SZ): Issuance of H shares has obtained approval from the China Securities Regulatory Commission.

JXR(01951) suggests launching an asset-backed securities program on the Shanghai Stock Exchange.

STREAM IDEAS (08401): Huang Zilu appointed as executive director.

RECOMMEND





